Masimo Corporation (MASI)

Market Cap	9.08B
Revenue (ttm)	2.04B
Net Income (ttm)	78.60M
Shares Out	53.54M
EPS (ttm)	1.45
PE Ratio	117.05
Forward PE	36.23
Dividend	n/a
Ex-Dividend Date	n/a

Volume	670,362
Open	168.93
Previous Close	170.00
Day's Range	166.97 - 173.22
52-Week Range	101.61 - 180.97
Beta	1.01
Analysts	Buy
Price Target	175.67 (+3.63%)
Earnings Date	Nov 5, 2024

About MASI

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 8, 2007
• Employees: 3,800
• Stock Exchange: NASDAQ
• Ticker Symbol: MASI
• Website: https://www.masimo.com

Financial Performance

In 2023, Masimo's revenue was $2.05 billion, an increase of 0.60% compared to the previous year's $2.04 billion. Earnings were $81.50 million, a decrease of -43.21%.

Analyst Forecast

According to 7 analysts, the average rating for MASI stock is "Buy." The 12-month stock price forecast is $175.67, which is an increase of 3.63% from the latest price.

Price Target

$175.67

(3.63% upside)

Analyst Consensus: Buy